Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung Diseases
HighFlowMusc
Evaluation of the Physiological Effects of High Flow Nasal Canulae Oxygen Therapy During Exercise in Patients With Fibrosing Interstitial Lung Diseases
1 other identifier
interventional
16
1 country
1
Brief Summary
in this study, the investigators aim to describe the effects of highflow nasal canulae oxygen therapy (HFNC) on respiratory muscle function during exercise in patients with fibrosing interstitial lung diseases (ILD) during an endurance test
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2022
CompletedFirst Posted
Study publicly available on registry
May 13, 2022
CompletedStudy Start
First participant enrolled
November 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 23, 2024
CompletedNovember 23, 2022
November 1, 2022
2 years
April 6, 2022
November 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ptdi swing
To compare the change in transdiaphragmatic pressure between baseline and peak during inspiration (Ptdi swing) between HFNC and VM in patients with fibrosing Interstitial Lung Disease in stable state, at isotime.
during the intervention, at isotime
Secondary Outcomes (7)
PTPdi
during the intervention, at isotime
PTPoeso
during the intervention, at isotime
Poeso swing
during the intervention, at isotime
DeltaPtdi/DeltaEAdi
during the intervention, at isotime
SmO2
during the intervention, at isotime
- +2 more secondary outcomes
Study Arms (2)
Venturi mask
EXPERIMENTALPatients will be placed under oxygen therapy with Venturi mask at a constant flow of 15L/min and a set FiO2 of 50%. The real FiO2 will be mesured in the mask at rest.
High flow nasal canulae
EXPERIMENTALPatients will be placed under high flow nasal canulae oxygen therapy with a constant flow of 50L/min and the real FiO2 provided by Venturi mask.
Interventions
high flow nasal canulae is a oxygen therapy technic which allows the administration of warmed and humidified oxygen with a flow up to 50L/Min and a monitored FiO2. Physiological previous studies reported various effects of this technic especially on work of breathing. In our study the investigators aim to test this physiological property during exercise.
Ventury mask is a oxygen therapy technic which allows the administration with a mask of oxygen with a flow up to 15L/Min and a monitored FiO2.
Eligibility Criteria
You may qualify if:
- Cared for as part of a respiratory rehabilitation program (ADIR association)
- Presenting diffuse fibrosing interstitial pneumonitis, documented by CT scan data and whatever its etiology
- Presenting severe hypoxemia in ambient air (SpO2\<90%) during an exercise test (6-minute walk test or functional exercise test)
You may not qualify if:
- Patient with a contraindication to carrying out a respiratory rehabilitation program
- Tracheostomized patient
- Patient with a contraindication to the placement of a nasogastric tube
- Pregnant or breastfeeding women or women of childbearing age without effective means of contraception (a pregnancy test will be carried out)
- Protected adult patient (guardianship or curatorship)
- Patient deprived of liberty by court or administrative decision
- Refusal of patient participation or consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ADIR Associationlead
Study Sites (1)
ADIR association
Bois-Guillaume, 76230, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elise ARTAUD-MACARI, MD
ADIR Association
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2022
First Posted
May 13, 2022
Study Start
November 22, 2022
Primary Completion
November 23, 2024
Study Completion
November 23, 2024
Last Updated
November 23, 2022
Record last verified: 2022-11